Biological Scientists, All Other
AI replacement rate
60%This role is currently tracked with 2 timeline items plus a profile-based replacement estimate.
AI's capabilities are rapidly advancing in biological sciences, with new platforms automating complex data analysis, experimental design, and research workflows, leading to an increased replacement rate.
Replacement trend
Aggregated from periodic refresh snapshots- 2026-04-2034%
Why this role is rated this way
Structural baseAnthropic's Claude Science introduces an AI workbench for scientists to integrate tools and enable AI agents to run end-to-end analyses, checking citations and calculations, thereby automating significant parts of research.
Yaosu Technology secured significant funding to develop its '3DBioIntelligence' platform, featuring AI models for biological mechanism analysis, high-throughput automated experiments, and virtual cell modeling for drug discovery.
The development of specialized AI platforms indicates a growing capacity for AI to handle complex data transformation, analysis, and interpretation within biological sciences, reducing human dependency in these areas.
AI-powered tools are improving the automation of experimental systems and predictive modeling, which can significantly streamline the design and execution phases of biological research, impacting tasks with higher repetition and clearer rules.
Timeline
Relevant news and cases, newest firstAnthropic introduces Claude Science, an AI workbench for scientists to integrate tools and run analyses. Additionally, "耀速科技" secures funding to develop an AI-powered "3DBioIntelligence" platform for biological research and drug discovery, including virtual cell models. These developments significantly enhance the capabilities and workflows for biological scientists.
Open originalYaosu Technology secured nearly 200 million yuan in A+ round financing to further develop its "3D Bio Intelligence" platform, which includes enhancing AI models for biological mechanism analysis, implementing high-throughput automated experimental systems, accumulating multi-modal biological data, and constructing virtual cells and biological world models for drug R&D.
Open original